Trials / Unknown
UnknownNCT03818841
The Role of High-flow Nasal Cannula Therapy in the Treatment of Acute Carbon Monoxide Poisoning
High-flow Nasal Cannula Therapy in the Treatment of Acute Carbon Monoxide Poisoning
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Università degli Studi del Piemonte Orientale Amedeo Avogadro · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to test whether oxygen therapy delivered through high-flow nasal cannula devices in patients admitted to the emergency department for acute carbon monoxide poisoning is superior to the non-rebreathing oxygen face mask therapy with a 15 L/minute oxygen flow (currently the first-line therapy), in terms of reduction of carboxyhemoglobin (COHb) concentration and delayed neurological sequelae incidence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | High-flow nasal cannula device | Patients will be randomly allocated to this treatment |
| DEVICE | Non-rebreathing oxygen mask group | Patients will be randomly allocated to this treatment |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2022-02-01
- Completion
- 2022-02-01
- First posted
- 2019-01-28
- Last updated
- 2019-02-06
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03818841. Inclusion in this directory is not an endorsement.